We Are Las Vegas

FDA Halted Mammograms at Summerlin Hospital

The hospital ceased services in December 2025 after federal officials identified clinical image quality deficiencies.

Updated on Oct. 2, 2026 in Healthcare

Isometric editorial illustration of a sterile medical calibration lens and detector plate, symbolizing clinical diagnostic quality standards.
The FDA ordered Summerlin Hospital to suspend its mammography services in December 2025 following repeat findings of clinical image quality failures. AI Illustration. Upload story photo >

Live Poll

Do you trust local medical facilities to consistently maintain high clinical quality and safety standards?

Summerlin Hospital Medical Center suspended mammography services on December 11, 2025, after a federal review revealed significant image quality failures. State health officials confirmed the facility lost its American College of Radiology accreditation following the discovery of repeat imaging lapses.

Why it matters

The suspension stems from systemic failures in how technologists and physicians managed image quality, leaving diagnostic accuracy for thousands of patients in question. The state is now mandating stricter oversight to ensure local medical facilities meet required clinical standards.

Federal inspectors identified clinical quality failures during an October 2025 review, prompting the hospital to lose its accreditation. The facility must now notify all patients who received exams between October 24, 2023, and December 11, 2025.

The players

Summerlin Hospital Medical Center

The medical facility where the FDA identified mammography image quality deficiencies.

FDA

The federal agency that ordered the cessation of mammography services.

Nevada Division of Public and Behavioral Health

The state agency responsible for overseeing health standards and issuing public notices.

American College of Radiology

The accrediting body that revoked the facility's credentials in December 2025.

The details

Reviewers found that technologists used poor positioning techniques, while staff failed to catch inadequate images or order necessary repeats. Following the FDA order, the facility was forced to cease all mammography operations. The Nevada Division of Public and Behavioral Health is now enforcing new oversight requirements to prevent similar lapses in image quality across the region.

Timeline

  1. October 24, 2023: Start date for the patient notification window.

  2. October 2025: Investigators performed a random image check.

  3. December 2025: The hospital lost its American College of Radiology accreditation.

  4. December 11, 2025: The FDA ordered the hospital to stop performing mammography.

  5. July 21, 2026: The state issued a bulletin regarding the service cessation.

Beyond the Strip

This service suspension represents an enforcement action under the federally mandated standards of the Mammography Quality Standards Act. It highlights the consequence of failing to meet the imaging benchmarks that all accredited facilities in the valley must maintain.

If you received a mammogram at Summerlin Hospital between October 24, 2023, and December 11, 2025, you should be included in the patient notification process. You may need to have your previous scans reviewed to determine if your specific images require repeat testing.

The takeaway

Patients affected by the imaging failures at Summerlin Hospital should ensure they receive the required notification and follow-up guidance. Keep a close watch on future state reports regarding local hospital accreditation to verify that your medical provider remains in good standing.

Further reading

For more updates on medical facility compliance, visit Las Vegas Healthcare.

Source note: This article includes information reported by AuntMinnie.

Live Poll

Do you trust local medical facilities to consistently maintain high clinical quality and safety standards?